Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients
-
* Corresponding author: Gabriela Riemekasten gabriela.riemekasten@charite.de
Arthritis Research & Therapy 2009, 11:R22 doi:10.1186/ar2614
Accesses
- Last 30 days: 116 accesses
- Last year: 1249 accesses
- All time: 4113 accesses
Cited by
BioMed Central: 1 citation
|
Editorial
The changing landscape of the clinical value of the PM/Scl autoantibody system Michael Mahler, Marvin J Fritzler Arthritis Research & Therapy 2009, 11:106 (26 March 2009) |
